HALB
Halberd Corp

2,741
Mkt Cap
$567,462.00
Volume
60,568.00
52W High
$0.003
52W Low
$0.0007
PE Ratio
0.00
HALB Fundamentals
Price
$0.0011
Prev Close
$0.0009
Open
$0.001
50D MA
$0.0012
Beta
0.72
Avg. Volume
981,618.05
EPS (Annual)
$0.00
P/B
-0.89
$1.71
Loading...
Loading...

About

Halberd Corp. is a development stage company, which engages in the research and development of antibodies and devices for the prevention, detection, and treatment of neurodegenerative diseases. It offers patented extracorporeal treatment that is applicable to various blood-borne and neurologic diseases such as PTSD/ CTE (Post Traumatic Stress Disorder/Chronic Traumatic Encephalopathy), Alzheimer's Disease, and Parkinson's Disease. The company was founded by Mark Sven Lundquist and John Christopher Maddox on January 26, 2009 and is headquartered in Jackson Center, PA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Halberd Corp?
What is the 52-week high for Halberd Corp?
What is the 52-week low for Halberd Corp?
What is Halberd Corp stock price today?
What was Halberd Corp stock price yesterday?
What is the Price-to-Book ratio of Halberd Corp?
What is the 50-day moving average of Halberd Corp?

Latest HALB News

View
Top Discussions